test-Bioprojet's orphan drug for EDS enters Phase III trials
16 November 2010
Ian Schofield
Please Login to read the full article.
16 November 2010
Ian Schofield
Please Login to read the full article.
RELATED CONTENT
NEWS
- UK govt offers "step change" in support for regenerative medicine
- Focus on Almirall: partnering, new products and mature markets are key targets
- Upsher-Smith begins Phase III trial of intranasal midazolam for epilepsy seizure clusters
- US Krystexxa launch in motion, as Savient touts gout drug for "an unmet medical need", but concedes ramp-up may be slow
COMMENT
